COVID-19 Impact on Pharmaceutical Packaging in Chemicals and Materials Industry

COVID-19 Impact on the Wound Healing in Healthcare Industry

  • Healthcare
  • Jun 04, 2021

COVID-19 Impact on the Wound Healing in Healthcare Industry

OVERVIEW  AFTERMATH OF COVID-19 AND GOVERNMENT ROLE

A recent SARS-CoV-2 virus has caused a general pandemic of respiratory disease called COVID-19. The infection initially showed up in Wuhan, a city of China in December 2019. The patients experiencing COVID-19 are dealt cautiously with all the safety measures, since this sickness spreads quicker through actual contact.

There are now numerous vaccines in use. The first mass vaccination programme commenced December 2020 and as of 15th February 2021, 175.3 million vaccine doses have been administered. 

World Health Organization (WHO) issued an Emergency Use Listing (EULs) for the Pfizer COVID-19 vaccine (BNT162b2) on 31st December 2020, issued another two EULs for two versions of the AstraZeneca/Oxford COVID-19 vaccine, manufactured by the Serum Institute of India and SKBio on 15th February 2021. On 12th March 2021, World Health Organization (WHO) issued a EUL for the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson Services, Inc.).

As per the World Health Organization (WHO) report, globally, as of 28th April 2021, there have been 148,329,348 confirmed cases of COVID-19 including 3,128,962 deaths reported to World Health Organization (WHO). As of 27th April 2021, a total of 983,410,283 vaccine doses have been administered.

As per the World Health Organization (WHO) report, in the United States of America, from 3rd January 2020 at 5:16pm CEST to 28th April 2021, there have been 31,783,375 confirmed cases of COVID-19 with 567,327 deaths reported to World Health Organization (WHO). As of 22nd April 2021, a total of 223,293,713 vaccine doses have been administered.

As per the European Centre for Disease Prevention and Control, as of week 2021-13, 27,513,674 COVID-19 active cases and 627,242 deaths have been reported in the EU/EEA.

Even though immunization is found for COVID-19, safeguards incorporate incessant hand-wash, wearing face veil and keeping up social separating.

The wound healing is pivotal as without regular wound care patients are susceptible of developing wound infections. As a result, patients tend to have risks for limb loss and loss of life. In this COVID-19 pandemic, the primary goal of wound care personnel should be providing the patients with satisfactory care to avoid their wounds from deteriorating and limiting redundant in-person visits to minimise the acquaintance to the virus for both healthcare and patients.

The non-healing wounds are a manifestation of multiple underlying medical problems. Most of the wound care patients have multiple comorbidities such as diabetes, hypertension and kidney disease which deem them as members of the high-risk population who could face severe consequences if they have COVID-19.

In light of the fiery impacts of the infection, there are hypothetical dangers that the viral contamination could delay the wound healing of the patients as there have been limited visits to the hospitals due to the lockdown imposed by the government in different countries.

IMPACT ON PRICE 

Because of COVID-19, the market is upset to a major level, the few foundations needs to stay shut while others to downsize the activities or put on pause extension plans as they attempted to endure the uncommon emergency.

The current COVID-19 episode has influenced essentially every industry on earth and global wound healing has no exemption. There has been a tremendous and sudden lessening in the volume of elective joint substitutions worldwide as well-being situation legitimately organize their COVID-19 reaction.

Now, as the demand for telehealth innovation is turning out to be very demanding by human-beings and this will make the market more competitive due to new and more innovative products that will be launched by the makers by decreasing the overall cost of the new and innovative wound healing products and medicines.

IMPACT ON DEMAND

Since the pandemic, due to lockdown situation, the economic growth of a country is declining day-by-day. And the manufacturing units for various items shut down due to the non-availability of man power.

There will be opportunities in the coming time for manufacturers of digital health technologies to position themselves for the COVID-19 recovery. When COVID-19 responses ease, there will be an excess of elective surgeries procedures in emergency clinics. The pre-appointment programs can help smooth out the planning, arrangement and conveyance of the surgeons and the doctors.

Cloud-based stages have an extraordinary preferred position in permitting the clinician and their representatives to design cases distantly while travel and medical clinic access limitations are set up. With the careful plans and embeds chose early, embed providers and emergency clinics have the chance to enhance their stock and creation (on account of patient-explicit custom parts) to effectively address the accumulation of cases once the circumstance permits.

For instance,

  • As such, integrating telemedicine into wound care during the outbreak aids in maintaining social distancing, preserving personal protective equipment and medical resources and obliterates unnecessary exposure for both vulnerable patients and high-risk healthcare workers.

IMPACT ON SUPPLY

Because of pertinacious COVID-19 lockdown, sanctions have been forced by administrations of different nations. These limitations and boundaries across nation’s borders prompted a diminishing in stockpile because of restricted materials and labour force and halting of assembly line.

Additionally, the manufacturers are also taking crucial steps to ensure the availability of raw materials by and also they have to look into the quality of products. But since the demand is increasing day-by-day, so as to meet the demand, the major manufacturers and suppliers are collaborating with each other’s to ensure the supply of raw materials.

STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS 

The key players engaged in global wound healing manufacturing are making improvements to keep the speed during COVID-19. They are taking every single choice cautiously so the development can be expanded on consistent schedule for the market. The manufacturers are likewise giving a great deal of consideration in the improvement of inventive items that can be utilized for the attractive impacts. Organizations working in the wound healing are embracing few systems including joint effort, arrangements, association and market development to improve their business. These essential choices by the organizations are required to give huge occasions to the market players working in the wound healing market.

For instance,

  • During the pandemic, all the strategic and operational decisions taken by B. Braun Melsungen AG is with consideration of the risks and imminent opportunities involved. The company follows the risk management protocols to avert any potential risks.

CONCLUSION

Local manufacturers are now adapting new and better characteristics to create enormous measure of muscular embeds in order to address the issue in coming fates and also the government is helping to defeat all the difficulties that are been faced in the creation of implants. It is estimated that the COVID-19 pandemic outbreak have negative impact on the growth of global wound healing market.

The growing prevalence of the chronic wound infection has necessitated the need for a stable healthcare network and adequate emergency medical services (EMS). However, certain challenges in research and development, loss of patent of the devices may tamper the market growth.

There is no data on the immunogenicity, safety or efficiency regarding the treatment of the patients with wound infections along with mild COVID-19 symptoms. The supply chain units are taking stringent measures and risk mitigation protocols to provide the devices to the manufacturers to the customers. The presence of key market players for the development and launch of the wound debridement devices will increase the net sales and may show a surplus growth in the market.

Despite the indication of a vaccination on the horizon, the pandemic is here to live for a considerable amount of time. Along with COVID-19 ongoing treatment, resource implementation in wound care should be able to match with the possible optimum patient outcomes. However, the treatment will remain same, irrespective of the SARS- COV-2 coinfection. When SARS-CoV-2 are circulating in the community, patients who require hospitalization should receive immediate wound bed preparation model, patient-centered care and timely intervention by a professional team during the ongoing COVID-19 pandemic. The guidelines for wound care management during COVID-19 pandemic are to mitigate the need for frequent wound debridement and reducing the number of necessary clinical visits.